Rea, D., Henry, G., Khaznadar, Z., Etienne, G., Guilhot, F., Nicolini, F., Guilhot, J., Rousselot, P., Huguet, F., Legros, L., Gardembas, M., Dubruille, V., Guerci-Bresler, A., Charbonnier, A., Maloisel, F., Ianotto, J.-C., Villemagne, B., Mahon, F.-X., Moins-Teisserenc, H., Dulphy, N. and Toubert, A. (2017) “Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study”, Haematologica. Pavia, Italy, 102(8), pp. 1368-1377. doi: 10.3324/haematol.2017.165001.